Join
Live feed
·
INSIDERFilingvia Quantisnow
Crescent Biopharma Inc. logo

SEC Form 4: Usman Nassim returned 34 units of Series Y Preferred Stock to the company, closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
CBIO· Crescent Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CBIO (Crescent Biopharma Inc.) and more on Quantisnow.